Paper
4 March 1999 Resonant fluorescence for multilevel systems in intense nonmonochromatic fields: possibilities for applications in laser medicine
Tamara Ya. Karagodova
Author Affiliations +
Proceedings Volume 3726, Saratov Fall Meeting '98: Light Scattering Technologies for Mechanics, Biomedicine, and Material Science; (1999) https://doi.org/10.1117/12.341392
Event: Saratov Fall Meeting '98: Light Scattering Technologies for Mechanics, Biomedicine, and Material Science, 1998, Saratov, Russian Federation
Abstract
The theory of resonant fluorescence of multilevel system in two monochromatic intense laser fields has been applied for investigating the temporal decay of magnetic sublevels of an atom. As for two-level system the triplet of resonant fluorescence is observed, for real atom being the multilevel system the multiplet of resonant fluorescence can be observed. The excitation spectra, defining the intensities of lines in the multiplet of resonant fluorescence, and shifts of components of spectra are shown. Typical temporal dependence of fluorescence intensity for magnetic sublevels of an atom having different relaxation constants is shown. The computer simulation of resonant fluorescence for simple systems can help to understand the regularities in temporal decay curves of atherosclerotic plaque, malignant tumor compared to normal surrounding tissue.
© (1999) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Tamara Ya. Karagodova "Resonant fluorescence for multilevel systems in intense nonmonochromatic fields: possibilities for applications in laser medicine", Proc. SPIE 3726, Saratov Fall Meeting '98: Light Scattering Technologies for Mechanics, Biomedicine, and Material Science, (4 March 1999); https://doi.org/10.1117/12.341392
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Luminescence

Chemical species

Tissues

Sodium

Magnetism

Laser therapeutics

Tumors

Back to Top